Residency · Residency · Dermatology

Seborrheic Dermatitis and the Malassezia Connection

Overview

Seborrheic dermatitis (SD) is a common, chronic, relapsing inflammatory dermatosis affecting sebaceous gland-rich areas. It manifests as erythematous patches with greasy, yellowish scale on the scalp, face, and trunk, affecting approximately 3 to 5 percent of the general population. Its pathogenesis is strongly linked to Malassezia yeasts and sebaceous gland activity.

Epidemiology

SD has three peak incidences: infancy (cradle cap), adolescence, and between ages 40 and 60. There is a male predominance, likely due to androgen-driven sebaceous gland activity. Prevalence and severity are markedly increased in HIV/AIDS (30 to 80 percent), Parkinson disease and other neurologic conditions, mood disorders and psychiatric illness, and organ transplant recipients. SD tends to be worse in winter due to cold, dry air and reduced UV exposure.

Pathogenesis

The Malassezia Connection

Malassezia (formerly Pityrosporum) are lipophilic, dimorphic yeasts that are part of the normal skin flora in sebaceous areas. Key species implicated include M. globosa, M. restricta, and M. furfur. Malassezia lacks fatty acid synthase and depends entirely on host lipids for survival. It produces lipases that hydrolyze sebaceous triglycerides, releasing unsaturated fatty acids — particularly oleic acid and arachidonic acid. Oleic acid disrupts the stratum corneum, causing irritation and scaling. Arachidonic acid metabolites promote inflammation. Critically, it is the host immune response to Malassezia, rather than the organism's burden, that determines whether disease develops: SD patients show altered immune reactivity rather than increased fungal load, with complement activation, cytokine release, and both T-cell mediated and innate immune dysregulation in response to Malassezia antigens.

Sebaceous Gland Activity

Disease correlates with areas of highest sebaceous gland density. Sebum provides the lipid substrate for Malassezia metabolism. Androgen influence explains the male predominance and onset at puberty. Abnormalities in sebum composition may predispose certain individuals.

Neurologic Association

Parkinson disease, stroke, spinal cord injuries, and facial nerve palsies are all associated with SD. The prevailing theories include increased sebum accumulation from immobility, autonomic dysfunction, altered facial sweating, and possibly the effect of dopamine deficiency on sebaceous gland regulation.

Immune Factors

In HIV/AIDS, SD severity inversely correlates with CD4 count. Defective cell-mediated immunity allows Malassezia overgrowth. Immunosuppressive medications can trigger or worsen SD.

Clinical Presentations

Infantile Seborrheic Dermatitis (Cradle Cap)

Onset occurs within the first 3 months of life, presenting as thick, adherent, yellowish, greasy scale on the scalp that can extend to the face, retroauricular area, and diaper area. It is generally self-limited, resolving by 6 to 12 months. Leiner disease — generalized seborrheic erythroderma in infants — is a rare complication associated with complement deficiencies.

Adult Seborrheic Dermatitis

On the scalp, SD ranges from mild dandruff (pityriasis capitis) to thick adherent scale with erythema. On the face, it favors the nasolabial folds, eyebrows, glabella, and eyelid margins (blepharitis). The ears may show involvement of the concha, retroauricular folds, and external auditory canal. On the chest, petaloid (flower-petal shaped) patches appear on the presternal area. Intertriginous areas (axillae, inguinal folds) may also be affected, overlapping with inverse psoriasis.

Seborrheic Dermatitis in HIV/AIDS

HIV-associated SD has an explosive onset, widespread distribution (including unusual sites like the extremities), thick and inflammatory papular or plaque-like lesions, and is often refractory to standard therapy. It can be the presenting sign of HIV infection.

Differential Diagnosis

Psoriasis shows thicker, silvery scale with sharper margins, extensor distribution, and nail involvement — though "sebopsoriasis" represents an overlap entity with features of both. Atopic dermatitis is more pruritic with flexural distribution and a personal or family history of atopy. Tinea capitis or faciei will be KOH positive with positive dermatophyte culture and may cause hair loss. Rosacea shows papules, pustules, and flushing but no scale. Contact dermatitis follows contactant exposure distributions. Secondary syphilis may cause "moth-eaten" alopecia with palmoplantar involvement. Lupus erythematosus presents with a malar rash that spares the nasolabial folds — the opposite of SD. In infants, Langerhans cell histiocytosis should be considered if disease is petechial, erosive, or refractory to treatment.

Histopathology

The hallmark histologic feature is "shoulder" parakeratosis — mounds of parakeratosis at the edges of follicular ostia. Other findings include mild to moderate spongiosis, psoriasiform hyperplasia in chronic lesions, perivascular and perifollicular lymphocytic infiltrate with neutrophils, scale crust with neutrophils, and follicular plugging. Distinguishing SD from psoriasis histologically can be challenging.

Management

Scalp

Medicated shampoos are first-line: ketoconazole 2 percent (used twice weekly), zinc pyrithione, selenium sulfide 2.5 percent, ciclopirox 1 percent, or coal tar. The key technique is to leave the medicated shampoo on for 5 to 10 minutes before rinsing. Topical corticosteroids (fluocinolone acetonide oil, clobetasol shampoo) are used for flares.

Face and Body

Topical antifungals (ketoconazole 2 percent cream, ciclopirox 1 percent cream) form the maintenance backbone. Topical calcineurin inhibitors (pimecrolimus 1 percent cream or tacrolimus 0.1 percent ointment) are preferred for chronic facial use as steroid-sparing agents. Low-potency topical corticosteroids (hydrocortisone 1 to 2.5 percent or desonide) are used for acute flares, with limited duration on the face. The best approach combines antifungals for maintenance with short bursts of corticosteroid for flares.

Refractory Disease

For refractory cases, oral itraconazole (200 mg/day for 1 to 2 weeks) or fluconazole (200 to 300 mg/week) may be used. HIV should be ruled out if onset is sudden and severe in a young adult. Low-dose isotretinoin (off-label) reduces sebaceous gland activity. Narrowband UVB phototherapy is another option.

Infantile SD (Cradle Cap)

Management involves gentle removal using mineral oil or emollient applied before shampooing with a soft brush. Mild antifungal shampoo (ketoconazole) is used if disease persists. Low-potency topical corticosteroid is added for significant inflammation. The condition is generally self-limited, and parents should be reassured.

Sebopsoriasis

Sebopsoriasis describes the clinical and histologic overlap between SD and psoriasis, commonly seen in the scalp and facial distribution. It may represent a distinct phenotype or early psoriasis. Treatment addresses both components (antifungal plus anti-inflammatory), and patients should be monitored for progression to classic psoriasis.

<image>Clinical photograph panel of seborrheic dermatitis showing: (A) classic greasy yellowish scale on the scalp (dandruff to thick scale spectrum), (B) erythema and scale in the nasolabial folds and eyebrows on the face, (C) petaloid patches on the presternal chest, (D) infantile cradle cap with thick adherent scalp scale. Show diverse skin tones to illustrate how erythema may appear differently.</image>

<image>Diagram illustrating the Malassezia-sebaceous gland interaction in seborrheic dermatitis pathogenesis. Show Malassezia yeasts on the skin surface metabolizing sebaceous triglycerides via lipase activity, releasing oleic acid (barrier disruption) and arachidonic acid (inflammation). Include the host immune response with keratinocyte activation and cytokine release. Label the therapeutic targets: antifungals targeting Malassezia, anti-inflammatory agents targeting the immune response, and retinoids targeting sebaceous gland activity.</image>

<image>Histopathology illustration of seborrheic dermatitis showing characteristic "shoulder" parakeratosis at follicular ostia, mild spongiosis, superficial perivascular and perifollicular lymphocytic infiltrate with scattered neutrophils, and follicular plugging. Side-by-side comparison with psoriasis histology highlighting the distinguishing features.</image>

Clinical Pearls

Seborrheic dermatitis sparing the nasolabial folds should raise suspicion for lupus, which classically affects the malar area but spares the nasolabial folds. New-onset severe seborrheic dermatitis in a young adult should prompt HIV testing. SD of the eyelid margins (blepharitis) is best managed with eyelid hygiene (warm compresses, dilute baby shampoo scrubs) plus topical ketoconazole or selenium sulfide. Topical calcineurin inhibitors are the preferred maintenance therapy for facial SD to avoid corticosteroid-induced atrophy, telangiectasia, and perioral dermatitis. In infants, if "cradle cap" fails to resolve or is associated with petechiae, purpura, or hepatosplenomegaly, consider Langerhans cell histiocytosis and biopsy. Zinc pyrithione works through both antifungal and anti-inflammatory mechanisms and is well-tolerated for long-term maintenance.

References

• Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2):10.
• Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):185-190.
• Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13-26.
• Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments. Clin Cosmet Investig Dermatol. 2013;6:155-163.

Read this lecture as Markdown